×
07 April 2021

mySugr announces the integration of the NovoPen 6 and NovoPen Echo Plus into the mySugr Logbook

The connection of the Novo Nordisk® smart insulin pens with the mySugr Logbook is now available on iOS in the first country Sweden, with more markets to follow. Bringing data together and setting it into context provides patients and healthcare professionals with a broader picture of the individual diabetes therapy and aims to support its optimization.

Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop
01 March 2021

Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop

The Accu-Chek Insight insulin pump from Roche will be the first pump with a pre-filled cartridge that can be operated in loop mode. As part of DBLG1 System from Diabeloop, the Accu-Chek Insight insulin pump will enable people with diabetes to better manage their diabetes and improve their time in range.

Roche Logo
11 December 2020

Roche teams up with Diabeloop to advance the management of insulin pump therapy

The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes. By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche’s strategy of integrated Personalised Diabetes Management (iPDM).

Roche introduces a Remote Patient Monitoring solution at the 56th Annual Meeting of the European Association for the Study of Diabetes
21 September 2020

Roche introduces a Remote Patient Monitoring solution at the 56th Annual Meeting of the European Association for the Study of Diabetes

The Remote Patient Monitoring solution is an element of the RocheDiabetes Care Platform helping healthcare professionals to provide care when and where it is needed, thus enabling a more efficient and personalised approach to diabetes care.

Roche Logo
11 September 2020

Roche completes certification of all Class I medical devices in its diabetes care portfolio under the new Medical Device Regulation

Roche declares conformity with the new Medical Device Regulation (MDR) for all its Class I medical devices in its diabetes care portfolio. Ensuring compliance with the new MDR strengthens the company’s position as a leader and trusted partner in diabetes care providing products and services of highest quality and safety.

Media Contacts

Journalists are welcome to contact Roche Diabetes Care's media relations team. If you have a general or product-specific enquiry, or any other non-journalistic question, please contact your local Accu-Chek office directly to get guidance.
General contact for Journalists
Contact for Customers
All Media Contacts